期刊文献+

MR扩散加权成像在骨肉瘤新辅助化疗疗效评估中的价值 被引量:11

Assessment of the responses to neoadjuvant chemotherapy of osteosarcoma by diffusion-weighted MR image: initial results
原文传递
导出
摘要 目的探讨MRDWI对骨肉瘤新辅助化疗效果评估的价值。方法36例原发性骨肉瘤患者新辅助化疗(顺铂+甲氨喋呤+表阿霉素+异环磷酰胺)前、后进行常规MRI、DWI。检查采用1.5T超导型MR仪,测定化疗前、后肿瘤内活性肿瘤组织、坏死区及肿瘤平均ADC值变化。术后病理肿瘤坏死率评估按Huvos标准分级。用两独立样本t检验法检验化疗反应不同2组病例的各项指标。结果36例化疗后肿瘤内活性肿瘤组织和坏死区的ADC值分别为(1.06±0.30)×10^-3mm^2/s和(2.39±0.44)×10^-3mm^2/s,坏死区ADC值明显高于活性肿瘤组织,两者间差异有统计学意义(t=3.515,P〈0.05)。25例化疗反应良好组肿瘤平均ADC值由化疗前的(1.18±0.19)×10^-3mm^2/s增加至化疗后(2.27±0.20)×10^-3mm^2/s,11例化疗反应不佳组的平均ADC值从化疗前(1.45±0.11)×10^-3mm^2/s增加至化疗后(1.83±0.16)×10^-3mm^2/s,两组间化疗前后ADC值变化差异有统计学意义(t=4.981,P〈0.01)。结论DWI能够区分新辅助化疗后骨肉瘤内活性肿瘤组织与坏死组织,进而对骨肉瘤化疗效果的评估有一定价值,结合常规MR检查,对手术计划的制定、术后化疗方案的选择及判断患者预后有重要帮助。 Objective To determine the utility of diffusion-weighted magnetic resonance imaging ( MR DWI ) in detecting tumor necrosis with histological correlation after neoadjuvant chemotherapy. Methods Conventional MR/ and DWI were obtained from 36 patients with histological proven osteosareoma. Magnetic resonance examinations were performed in all patients before and after 4 cycles of preoperative neoadjuvant chemotherapy. Apparent diffusion coefficients (ADC) were calculated. The degree of tumor necrosis was assessed using the histological Havos classification after chemotherapy. t-test was performed for testing changes in ADC value between the 2 groups. P value less than 0. 05 were considered as a statistically significant difference. Results The differences in ADC between viable [ (1.06 ±0. 30) × 10^-3mm^2/s] and necrotic [ (2. 39 ±0. 44) × 10^-3mm^2/s] tumor were significant (t = 3. 515 ,P 〈0. 05). Changes in ADC value was greater in good responses to neoadjuvant chemotherapy than in poor responses, the ADC value in good responses was increased from (1.18 ±0. 19) × 10^-3 mm^2/s to (2. 27±0. 20) × 10^-3 mm^2/s, the corresponding value in poor responses was increased from (1.45 ± 0. 11 ) × 10^-3 mm^2/s to (1.83 ±0. 16) × 10^-3 mm^2/s. There was significant difference in changes of ADC values between good responses and poor responses ( t = 4. 981, P 〈 0. 01 ). Conclusion Diffusion-weighted MRI permits recognition of tumor necrosis induced by chemotherapy in osteosarcoma. DWI is correlated directly with tumor necrosis. They have potential utility in evaluating the preoperative chemotherapy response in patients with primary osteosarcoma.
出处 《中华放射学杂志》 CAS CSCD 北大核心 2009年第6期571-574,共4页 Chinese Journal of Radiology
基金 上海市科学技术委员会重点项目基金资助(05JC14030)
关键词 骨肉瘤 药物疗法 磁共振成像 弥散 Osteosarcoma Drug therapy Diffusion magnetic resonance imaging
  • 相关文献

参考文献16

  • 1De Baere T,Vanel D,Shapeero L,et al.Osteogenic sarcoma after chemotherapy:evaluation with contraat material-enhanced subtraction MR imaging.Radiology,1992,185:587-592.
  • 2Enneking WF.A system of staging musculeskeletal neoplasms.Instr Coupe Lect,1988,37:3-10.
  • 3Huvas AG,Rosen G,Marcove RC.Primary oateogenic sarcoma:pathologicaspects in 20 patients after treatment with chemotherapy en bloc resection,and prosthetic bone replacement.Arch Pathol Lab Med,1977,101:14-18.
  • 4Philipp L,Michael F,Maythem S,et al.Ostengenic sarcoma:noninvasive in vivo assessment of tumor necrosis with diffusianweighted MR imaging.Radiology,1998,206:227-235.
  • 5Bammer R.Basic principles of diffusion-weighted imaging.Eur J Radiol,2003,45:169-184.
  • 6Reddy JS,Mishra AM,Behari S,et al.The role of diffusionweighted imging in the differential diagnosis of intrecranial cystic mass lesions:a report of 147 lesions.Surg Neuol,2006,66:246-250.
  • 7Lang P,Wendland MF,Saced M,et al.Oateogenic sarcoma:noninvasive in vivo assessment of tumor necrosis with diffusionweighted MR imaging.Radiology,1998,206:227-235.
  • 8Thceny HC,Keyzer FD,Chen F,et al.Diffusian-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhnhdomyesarcoma in ratsl.Radiology,2005,234:756-764.
  • 9Thceny HC,De Keyzer F,Vandecaveye V,et al.Effect of vascular targeting agent in rat tumor model:dynamic contrastenhanced versus diffnsion-weighted MR imaging.Radiology,2005,237:492499.
  • 10Lee KC,Hall HD,Hoff BA,et al.Dynamic imaging of emerging resistance during cancer therapy.Cancer Ree,2006,66:4687 -4692.

同被引文献105

引证文献11

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部